TG Therapeutics | Fremdkapital



Loan Capital Veränderung Datum
AbbVie USD 64.53B 4.19B 2025-03
Alaunos Therapeutics USD 0 0 2024-12
Amgen USD 53.76B 253M 2025-06
Ardelyx USD 150.85M 50.15M 2024-12
Arrowhead Research USD 200.33M 8.59M 2025-06
Bayer EUR 31.71B 3.31B 2025-06
Biogen USD 6.28B 1.74B 2025-06
Corcept Therapeutics USD 0 0 2025-03
Dynavax Technologies USD 220.75M 39.75M 2025-06
Gilead Sciences USD 22.14B 6M 2025-06
J&J USD 38.36B 7.7B 2025-03
Novartis USD 24.06B 2.4B 2025-06
PTC Therapeutics USD 2.13B 1.85B 2025-06
Regeneron Pharmaceuticals USD 1.99B 719.7M 2025-06
Roche Holding CHF 32.1B 1.94B 2024-12
TG Therapeutics USD 245.04M 608K 2025-06
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12


TG Therapeutics Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.